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pseudotumor. Bilateral involvement of IGM has been reported in a few cases. To our knowl-
edge, this study is the largest series of bilateral cases to date. The goals of this study were
to present clinical features of bilateral IGM and to evaluate the results of treatments.
Materials and methods: We performed a retrospective review of the idiopathic granulomatous
mastitis database from 2010 to 2013. Ten female patients who met required histologic and clin-
ical criteria of IGM in both breasts were included in study. Demographic data, clinical findings,
medication history, and radiologic findings are presented.
Results: The mean age at onset of the disease was 38.4  8.3 years (range: 29e52 years). Nine
patients had no recurrence during a mean follow-up period of 21 months (range: 11e26
months). Additionally, the median time to second breast involvement was 15.6 months.
Conclusion: Bilateral IGMs have a higher rate of more relapse and greater resistance to medical
therapies than do unilateral IGMs. Surgical management should be avoided unless all medical
treatment options have been exhausted. Nevertheless, expectant management seems a
rational option for the treatment of bilateral IGM.
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Bilateral idiopathic granulomatous mastitis 131. Introduction
Idiopathic granulomatous mastitis (IGM), also known as
idiopathic granulomatous lobulitis, is an uncommon, benign
inflammatory pseudotumor that was first reported by
Kessler and Wolloch in 19721. Clinically, IGM presents as a
palpable hard lump with erythematous skin changes or
lymph node involvement, which may lead to nipple
discharge or retraction, sinus formation, breast atrophy,
and “apple jelly” scars2e8. IGM is usually unilateral and can
be seen in all quadrant regions, except for the subareolar
area9,10.
Few cases of bilateral involvement have been reported
in the literature11e13. To our knowledge, this study, which
includes 10 bilateral IGM cases, is the largest series of
bilateral cases to date. The goals of this study were to
present the clinical features of bilateral IGM and to eval-
uate the results of treatment.
2. Materials and methods
Between 2010 and 2013, 10 female patients who met the
required histologic criteria of IGM in both breasts were
included in this retrospective study. The patients were
referred to our mastitis study group from the Outpatient
Departments of the General Surgery and Infectious Diseases
Clinics. Our study group included three infectious disease
physicians, two radiologists, two pathologists, and two
breast surgeons. The diagnosis was confirmed by core bi-
opsy of the suspicious breast lesions and biopsy specimens
taken from the abscess wall. The pathological criteria for
the diagnosis of IGM were the presence of the characteristic
histopathological features of a noncaseating granulomatous
inflammation centered on breast lobules, in the absence of
any evidence of specific underlying causes. The presence of
epithelioid histiocytes, lymphocytes, plasma cells, poly-
morphonuclear leukocytes, and multinucleated Langhans-
type giant cells without caseous necrosis were demon-
strated in each case. Treatment outcomes were evaluated
by physical examination and ultrasonography (US). The
clinical data in terms of the presentation, histopathology,
management, recurrence, discharge from the clinic, and
follow-up at monthly intervals were analyzed by a review of
the medical records. The Ethics Committee of Istanbul
University Cerrahpasa Medical School, Istanbul, Turkey
approved the study. The document number is 83045809/
604/02-15545/Date: June 5, 2014.
3. Results
3.1. Demographic data and clinical findings
Table 1 provides the clinical characteristics of the patients.
The mean age at onset of the disease was 38.4  8.3 years
(range: 29e52 years). The patients had no history of breast
carcinoma and no family history of granulomatous mastitis.
All but two patients were of reproductive age, and all were
parous. The parity of the patients ranged from two to five,
with a mean parity of three. None of the patients had a
recent history of pregnancy at the time of the presentation;the shortest and longest intervals after childbirth were 1
year and 10 years, respectively. None of the patients were
breast-feeding. None of the patients had a history of
tuberculosis or systemic granulomatosis, but three had a
family history of tuberculosis.
The most common presenting symptom was a hard mass,
which was detected in all of the patients (n Z 10; 100%).
Additionally, seven presented with redness of the skin
(70%), and draining sinuses (fistulas) or discharge from the
breast skin (n Z 7; 70%). Nine patients had no recurrence
during a mean follow-up period of 21 months (range: 11e26
months). Only one patient had static disease, at a follow-up
duration of 26 months (Fig. 1).
3.2. Radiologic findings
The most useful method for evaluating the radiologic
appearance of IGM is sonography. The technique defines
valuable data for infectious conditions such as effusions,
inflammation of parenchyma and fatty tissues, abscess
formations, fistula tracts. These are the key findings for
discriminating the suspected lesions from malignancy. In-
formation of the patients’ history is essential to assess
before evaluation. Sonography examination showed a
hypoechoic collection in nine patients (90%), solid lesion in
one patient (10%), thickening of the breast skin in eight
patients (80%), fistula tracts in four patients (40%), and
ductal fillings and postobstructive dilatation in three pa-
tients (30%). Mammographic findings were nonspecific in
the three patients who underwent mammograms. Magnetic
resonance imaging (MRI) evaluation may demonstrate the
extension of the disease and may be used to clarify the
suspected diagnosis. MRI was performed for three cases;
asymmetrical enhancement with nonspecific contrast
enhancement kinetics and fluid collections were common.
3.3. Medication history
All patients (100%) had previously taken antibiotics, six
patients (60%) had undergone drainage before presenting
at our clinic and four patients (40%) (Cases 1, 7, 8, and
10) were treated with a second course of antibiotics
(Table 1).
We sent all the biopsy samples to the histopathology
department. The characteristic caseating granulomas for
TB was observed only in one and this sample was sent for TB
culture as well. All were stained with Periodic Acid Schiff
(PAS) and Ehrlich Ziehl Neelsen (EZN) to demonstrate the
microorganisms within the tissue; all remained negative.
Case 1 had two recurrences and received antibiotics
and meloxicam. The patient was offered steroid treat-
ment but refused. Following cessation of medications, the
patient had expectant conservative management followed
by complete spontaneous recovery. Cases 8 and 10 showed
complete disease resolution and no recurrence with
expectant management. Case 7 had a history of antitu-
berculous therapy and a complete recovery of IGM in her
left breast, and she was referred to us for a lump affecting
the right breast. No previous pathological or microbio-
logical data regarding tuberculosis were available. Core
needle biopsy was performed, and the specimen was
Table 1 Clinical characteristics of patients with bilateral IGM.
Patient’s characteristics Case 1 Case 2 Case 3 Case 4
Age (y) 52 51 30 33
Parity 3 4 4 2
Past lactation Yes Yes Yes Yes
Oral contraceptive use No No No No
Tobacco smoking Yes No Yes Yes
Trauma history to the breast No No No No
Medical history DM Hashimoto’s thyroiditis No No
Family history in relation
to TB
No No Yes No
First admission to us No No No No
Presentation time 8 y after
childbirth
6 y after
childbirth
5 y after
childbirth
2.5 y after
childbirth
Total duration of breast-
feeding (mo)
36 17 60 7
Initial complaint A hard mass A hard mass and redness
of the skin
A hard mass and
redness of the skin
A hard mass and
redness of the skin
Time from onset of symptoms
to diagnosis (mo)
6 24 14 12
First affected breast side Right Right Left Right
Duration for the second
breast involvement (mo)
6 12 12 3
Size and location of mass in
right breast
2 cm, Upper inner
quadrant
2.5 cm, Upper inner
quadrant
3 cm, lower inner
quadrant
4 cm, Upper inner
quadrant
Size and location of mass in
left breast
2.5 cm, Upper inner
quadrant
2 cm, Upper outer
quadrant
3 cm upper quadrant
close to aerola
4 cm, Upper outer
quadrant
Core needle biopsy Yes Yes Yes Yes
Tuberculin skin test (mm) 20 Anergic 28 9
Acid fast stain Negative Negative Negative Negative
Rose Bengal Negative Negative Negative Negative
Radiologic tool US US US US
Abscess drainage Yes Yes Yes Yes
Antibiotics Amoxicillin-clavulanate Amoxicillin-clavulanate Ceftidoren pivoxil Ceftriaxon þ
ornidazol
Steroid therapy No Previously Yes Yes
Antituberculous therapy No Yes No No
Recurrence Yes Yes Yes Yes
Outcome Healed Healed Healed Healed
Unsightly scars Yes, bilateral Yes, bilateral Yes, bilateral Yes, bilateral
DM Z diabetes mellitus; IGM Z idiopathic granulomatous mastitis; US Z ultrasonography.a The data are not available due to
histopathological sampling of outer clinic.
14 M. Velidedeoglu et al.confirmed to be granulomatous mastitis; bacterial culture
was negative. This patient was managed conservatively
with regular clinical and radiological surveillance. After 2
months of follow-up, the patient showed complete re-
covery. One month later, she received meloxicam 15 mg
once per day for 1 month to treat her pain. Until 2013,
none of these four patients recurred without medication.
Four (40%) patients (Cases 3, 4, 6, and 9) were treated
with oral prednisolone for 6 weeks at an initial dose of
0.5 mg/kg/d in divided doses (4 þ 2), which were tapered
slowly with clinical improvement. Of these, Case 3
developed recurrence when the prednisolone dose was
tapered. As the dose was increased, the patient seemed
to respond, but the medication was stopped because she
became pregnant. She underwent expectant conservative
management, and experienced complete spontaneous
recovery. Case 4 developed recurrence 2 months after acomplete recovery following cessation of steroid therapy.
Nonetheless, the recurrent disease responded well to a
second course of oral prednisolone and the dose was
tapered slowly. However, after a short time period, she
again developed recurrence. Expectant conservative
management was preferred, and the patient experienced
complete spontaneous recovery after 5 months. Interest-
ingly, this patient became pregnant during this recovery
period. Case 9 showed complete recovery after a course
of steroid therapy. Case 6 developed recurrence following
cessation of steroid therapy, but the patient showed
complete recovery after a second course. Case 2 had no
clinical response to steroid treatment; however, the pa-
tient showed complete remission after undergoing com-
bined antituberculous therapy (rifampicin, ethambutol,
and isoniazid) for 6 months. Case 5 had no response to
antituberculosis treatment, so she received oral
Case 5 Case 6 Case 7 Case 8 Case 9 Case 10
34 40 43 32 29 40
2 4 5 2 3 3
Yes Yes Yes Yes Yes Yes
No No For 45 d 15 y ago No No No
Yes Yes No Yes No No
No No No No No No
No No No No No No
Yes No Yes No No No
No No No No No No
5 y after childbirth 1 y after childbirth Over 2 y after
childbirth
10 y after childbirth 4 y after childbirth 6 y after childbirth
Over 12 mos 48 120 12 27 60
A hard mass and
redness of the skin
A painful hard
mass
A hard mass and
redness of the skin
A painful hard mass A hard mass and
redness of the skin
A hard mass and
redness of the skin
15 14 30 12 4 9
Left Left Left Right Left Left
15 8 48 24 4 24
6 mm, Upper outer
quadrant
1 cm, Upper outer
quadrant
4 cm, Upper outer
quadrant
3 cm, Upper inner
quadrant
1 cm, Upper outer
quadrant
3 cm, Upper inner
quadrant
2 cm, Upper outer
quadrant
No data (left lesion
4 y ago)
3 cm, Upper inner
quadrant
3 cm, Upper outer
quadrant
No data(left lesion
2.5 y ago)
Yes Yes Yes Yes Yes Yes
17 8 20 8 9 Not performed
Negative Negative Negative Negative Negative Negative
Negative Negative Negative Negative Negative Negative
US US US US US US
Yes Yes No Yes Yes Yes
Amoxicillin-
clavulanate
Amoxicillin-
clavulanate
Fusidic acid Amoxicillin-
clavulanate
Amoxicillin-
clavulanate
Ciprofloxacin þ
Metronidazole
Yes, later Yes No No Yes No
Yes, initial No Previously No No No
Yes Yes Yes Yes Yes Yes
Resistant Healed Healed Healed Healed Healed
Yes, in left breast Yes, in left breast Yes, in right breast Yes, in right breast Yes, in left breast Yes, in left breast
Bilateral idiopathic granulomatous mastitis 15prednisolone. She recurred twice following cessation of
steroid therapy because of intolerance, but showed a
complete response thereafter. After 2 years, she experi-
enced a second recurrence, which is at present being
treated with antibiotic therapy. There was a notable delay
between onset of symptoms and diagnosis, a median of 14
months in our study. Additionally, the median time to
second breast involvement was 15.6 months (Figs. 2e4).4. Discussion
IGM is a rare, nonmalignant, chronic inflammatory breast
condition of unknown etiology that has received little
attention in the literature11. Almost 200 cases have been
reported during the past three decades, with most
cases occurring in females from Mediterranean countries
(Turkey and Jordan) and Asia (China, Arabia, and
Malaysia)2,3,5,11,14e18. Although no ethnic predispositionhas been documented, underdiagnosis of tuberculosis
mastitis might be a major reason for the increased
prevalence19,20.
The diagnosis and treatment of IGM remains challenging.
IGM can mimic breast abscess or inflammatory breast can-
cer in terms of physical and radiological findings. It typi-
cally presents as a unilateral palpable firm breast mass,
with occasional nipple discharge, peau d’orange change,
erythema, nipple inversion, breast asymmetry, draining si-
nuses, and scars, which are manifestations of intrinsic in-
flammatory or neoplastic breast disease1,2,8,16,21. Abscess
and fistula formation, ulceration, deformity of the breast,
and unsightly scars are common complications of IGM.
Although this disease is not life-threatening such as other
malignancies, it seriously depresses the social life of the
patient3,16,17,21e24.
All of our patients had hard masses as the initial
complaint, which were painful in only two patients. Six
(60%) patients had redness of the skin. There was a
Figure 1 The picture presents the deformation of the breast
due to skin fistulas of IGM. IGM Z idiopathic granulomatous
mastitis.
Figure 2 Common sonographic findings of IGM (AeC). (A) The
most common finding is hypoechoic collections without well
defined contours; (B) skin thickening secondary to inflamma-
tion should be compared with contralateral breast; right breast
skin was thickened compared with the left breast; and (C)
hypoechoic fistula tracts is specific finding and should be fol-
lowed due to fistula formation. IGM Z idiopathic granuloma-
tous mastitis.
16 M. Velidedeoglu et al.tendency for local recurrence and delayed wound healing.
All of our patients had at least one recurrence, and most
experienced inadequate or no response to various treat-
ment modalities.
IGM is seen mostly in females of childbearing age with a
history of pregnancy and lactation in the previous 5e6
years9,11,25. Although the youngest and oldest females ever
reported were aged 11 years and 83 years, respectively, the
disease usually appears in the breast in the third or fourth
decade3,17,19. However, younger patients were reported in
recent trials2,26e30. In our study, the mean age of patients
at onset of the disease was 38.4 years.
There was a notable delay between onset of symptoms
and diagnosis, a median of 14 months in our study. As IGM is
rare, this disease is not routinely considered as a differ-
ential diagnosis of a simple breast abscess. Surgical
drainage or US-guided aspiration is commonly preferred in
practice in place of core-needle biopsy or incisional biopsy
from the abscess wall, which may explain the prolonged
time to diagnosis. The median time to second breast
involvement was 15.6 months. No response to antibiotics
was observed in three of the 10 unilateral mastitis cases
before the second breast was involved. Two patients
showed no response to antibiotics and steroid therapy
before bilateral involvement. One patient showed a partial
response to antibiotics, but bilateral involvement occurred
thereafter. Three patients showed a complete response (1
responded to antibiotics, 1 to antibiotics and steroids, and
1 to antibiotics and abscess drainage), but they later
developed bilateral involvement. Only one patient showed
complete disease resolution after antituberculosis treat-
ment; unfortunately, the other breast showed involvement
48 months later. We concluded that bilateral IGMs were
resistant to medical treatment, and tended to relapse and
recur.
All of our patients had a history of pregnancy, were
parous, and had breast-fed. No patient experienced
symptom-onset during lactation. These results are in
accordance with previous reports that pregnancy and
breastfeeding conditions are associated with an increased
risk of IGM15,26,31e34. However, Azlina et al18 and Fletcheret al35 found no association with lactation. In Cases 3 and 4
in our series, the medication was stopped because the
patients became pregnant. These patients had expectant
conservative management, and experienced complete
spontaneous recovery. It is unclear whether being pregnant
Figure 3 (A,B) MRI images of bilateral IGM. (A) Contrast
enhanced T1 weighted reformat substraction (2nd minute)
image shows wide asymmetrical nonmass enhancement in right
breast and retroareolar disease in left. (B) Corresponding color
overlay T1 weighted axial scan provided by the computer-aided
diagnosis (CAD) system represents nonspecific contrast
enhancement kinetics in both breasts. IGM Z idiopathic
granulomatous mastitis; MRI Z magnetic resonance imaging.
Figure 4 The picture presents the bilateral synchronous
involvement in a 34-year-old woman.
Bilateral idiopathic granulomatous mastitis 17or receiving expectant management therapy contributed to
their recovery. Kaur et al36 reported that prolonged breast-
feeding might cause long-term distension of acini and
ducts, causing them to rupture. They suggested that this
factor might cause a granulomatous response. Baslaim
et al2 opposed this idea; they reported that patients,
especially nursing mothers who had breast-fed from one
breast only, developed the disease in the contralateral
breast.
The etiology of IGM is unclear; however, many factors,
such as local irritants, oral contraceptives, nicotine addic-
tion, and breast trauma, have been consid-
ered2,3,9,15,16,30,37,38. No patients included in the studies by
Ozel et al30, Azlina et al18, or Neel et al39 used oralcontraceptive hormones. Only one of our patients used oral
contraceptives for a short period 15 years ago. The patients
in the study by Azlina et al18 were nonsmokers. In addition,
the patients had no history of local trauma to the breast in
the Ozel et al30 study. In our study, six patients were
smokers, but none reported a history of local trauma. An
association between periductal mastitis (but not IGM) and
nicotine addiction has been established, as seen in more
than half of our patients (60%); moreover, smoking may
delay recovery and extend IGM disease involvement to the
second breast.
Although unilateral IGM is typical in previous reports,
bilateral involvement has been included in only a maximum
of two patients in these studies4,12,30. Bilateral involvement
has been reported at a lower frequency, and we found no
reports of a bilateral IGM series. Some authors reported
more common involvement of the right breast16,19,35,
whereas others reported left or equal involvement30,39. In
our study, the left breast was the first affected in six of 10
patients.
For an accurate diagnosis, IGM must be differentiated
from other disorders such as tuberculosis, sarcoidosis,
foreign body reaction, ductal ectasia, mycotic infection,
Wegener’s granuloma, and histoplasmosis40. Diagnostic
tests for tuberculosis include the purified protein derivative
(PPD) skin test, in vitro interferon-gamma assay and poly-
merase chain reaction. Ziehl-Neelsen (ZN) stain PPD and
routine histology studies are sometimes insufficient to
exclude tuberculosis mastitis16,41,42. In our study, periodic
acid-Schiff (PAS) and ZN acid-fast stains failed to identify
specific causative organisms in any of the 10 patients. The
PPD skin test was not performed in one patient. Four pa-
tients had positive PPD skin test results (> 10 mm in-
durations). Case 2 was anergic for PPD, and she did not
respond to steroid treatment; therefore, she commenced
combined antituberculous therapy (rifampicin, etham-
butol, and isoniazid) for 6 months and showed complete
remission. Further differential diagnoses were negative,
including a chest X-ray, the Rose Bengal test, and the
antidsDNA test.
US, mammography, and MRI have limited roles in dis-
tinguishing granulomatous mastitis from malignancy.
18 M. Velidedeoglu et al.Mammographic examination may show a focal asymmetrical
density in dense breast parenchyma or a mass with a
recognizable margin in fatty breasts. US has been used to
describe the disease as inhomogeneous hypoechogenicity
with internal hypoechoic tubular lesions4,10,19,25,43e45. It is
possible to discriminate benign neoplastic lesions from
cancer using dynamic contrast-enhanced MRI; however, this
method has lower specificity for distinguishing granuloma-
tous mastitis from breast cancer. Therefore, MRI may sup-
port US and mammography findings in distinguishing benign
inflammatory lesions from malignant lesions5,45e47. MRI aids
the surgical approach by delineating the extent of the
disease, as edema of the breast skin and tissue prevent
precise evaluation by US12. In our study, US revealed locu-
lated fluid collections of various sizes and ill-defined
hypoechoic masses in three cases. Two patients under-
went breast MRI previously in other centers. In one case,
ductal carcinoma in situ was suspected based on MRI;
however, US-guided biopsy proved the diagnosis to be IGM.
Consequently, there are no IGM-specific radiological find-
ings. US and mammography are used to rule out breast
cancer in centers that have experienced numerous cases of
IGM. Diagnosis is confirmed on tissue sampling biopsy by
revealing noncaseating granuloma with epithelioid histio-
cytes, giant cells, plasma cells, and eosinophils confined
within breast lobules48.
No clear consensus exists in the literature regarding the
optimal treatment approach for IGM, as none seems to be
ideal. Treatment options include antibiotics, steroids,
methotrexate (MTX), azathioprine, drainage of the wound,
wide surgical resection, mastectomy, and expectant man-
agement with close follow-up49e54. Aggressive surgery, such
as wide resection or mastectomy, is an accepted treat-
ment7,15,55, whereas some recommend a conservative
approach17,39. In addition to being therapeutic, surgical
excision provides a definitive diagnosis56. Involvement of
oncoplastic surgery, such as mastectomy, followed by
autologous breast reconstruction and steroids are alterna-
tive treatments for severe and intractable cases33. How-
ever, surgical resection can also be associated with
complications, including recurrence rates as high as 50%,
poor wound healing, sinus tract or abscess formation, and
disfigurement9,15e17,22,33,40,57e59. None of our patients with
bilateral IGM underwent surgical resection.
Regarding conservative management, steroids as a pri-
mary treatment have been shown to be beneficial for
shrinking the lesion both pre- and postoperatively in per-
sisting masses60,61. DeHertogh et al60 first reported that
high-dose prednisone was more effective in recurrent or
refractory cases. Many clinicians recommend an initial
treatment of 30e60 mg prednisone orally, which is tapered
gradually over several weeks (from 1 week to 22
months)18,19,22,24,28,40,41,44,52,53,62. In our study, four (40%)
cases were treated with oral prednisolone for 6 weeks at an
initial dose of 0.5 mg/kg/d in divided doses (4 þ 2), which
were tapered slowly with clinical improvement. Because
continued high doses of steroids until complete resolution
may be necessary51,60, the patients should be observed
closely for side effects, such as glucose intolerance and
Cushing’s syndrome, as well as weight gain, avascular ne-
crosis, depression, and cataracts13,20,63. One should also
take into account relapses following withdrawal of thetherapy or tapering off the dose57,60. One of our patients
relapsed when the steroid dose was tapered-off. Two pa-
tients developed recurrence after a complete recovery
following cessation of steroid therapy. Only one of four
patients who was given prednisone showed complete re-
covery after a course of steroid therapy, and no relapse
occurred. However, no relationship was detected between
the second breast involvement and the withdrawal of the
steroid therapy or tapering off the dose in our patients.
As steroids exacerbate infectious disease, all suspicious
infectious etiology should be excluded before commencing
steroids33,64. If there is a likelihood of a superinfection
because of the presence of inflammatory signs, antibiotics
as an initial treatment may be offered until a definitive
diagnosis is reached, otherwise antibiotics have no thera-
peutic value for true cases of IGM62. Our policy is to
perform surgical drainage and offer antibiotics prior to
starting systemic corticosteroids if the disease is compli-
cated by abscess. Even though it was rarely investigated,
immunosuppressive therapy including MTX and azathioprine
has been considered an alternative option in cases of
recurrence, resistance, and side effects of predni-
sone26,53,57,65. We did not prefer this medication for our
patients.
Complicated and resistant cases might benefit from
steroids after excision19. Gurleyik et al58 recommended
consecutive surgical excision of the remaining tissue after
steroids and claimed that this treatment would provide
better cosmesis and lower recurrence. The surgeon as well
as the patient should have patience during the course of
the disease because it is characterized by slow resolution
and tends to gradually resolve spontaneously2. Observation
without any therapy, known as expectant conservative
management, is an effective treatment approach63; how-
ever, close follow-up is essential. If untreated, spontaneous
regression in up to half of cases has been reported8. Thus
Lai et al3 reported complete disease resolution and no
recurrence in 50% of their patients with expectant man-
agement. Correlatively, six (60%) of our patients underwent
expectant conservative management and showed sponta-
neous complete recovery, as mentioned above. In the
absence of inflammatory signs in mild disease, expectant
management is preferred. If the condition worsens clini-
cally and radiologically, steroids are administered for 6e8
weeks at an initial dose of 0.5 mg/kg/d in divided doses
(4 þ 2), which are tapered slowly with clinical improve-
ment. As there is a strong tendency for persistence or
recurrence, surgery should be considered in untreatable
cases.
For follow-up, all of the patients were invited to our
mastitis study group for examination once or twice per
week until the symptoms resolved. The disease course was
followed by routine US at 1- and 3-month intervals. After
significant wound healing, 6-month follow-up US is
preferred. Finally, when the disease had resolved
completely, annual examination and screening were
advised.
Although the diagnosis and management of IGM remain
challenging, interdisciplinary approaches to this disorder
are essential. Unnecessary intervention and delays in the
diagnosis and treatment can be avoided by precise radio-
logical and pathological evaluation. In conclusion, bilateral
Bilateral idiopathic granulomatous mastitis 19IGMs have a higher rate of more relapse and greater resis-
tance to medical therapies than do unilateral IGMs. Surgical
management should be avoided unless all medical treat-
ment options have been exhausted. Nevertheless, expec-
tant management seems a rational option for the treatment
of bilateral IGM. Nicotine addiction may worsen the course
of the disease and lead to involvement of the second
breast.
To our knowledge, this is the first review of 10 bilateral
IGM cases in the literature. However, this study had limi-
tations, including its retrospective nature and descriptive
review of a limited number of cases. Although this study
does not provide strong evidence of the common features
of IGM, it does suggest the clinical features of bilateral
IGMs.Acknowledgments
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